Search Results
Imugene (ASX: IMU) – The ‘Holy Grail’ Of Cancer Treatment…?! | ASX CEO Interview 🚀📈
Imugene's new cancer therapy CD19 (OnCARlytics) considered the 'Holy Grail'
Imugene HER-Vaxx video ASX: IMU | AN EMERGING LEADER IN CANCER IMMUNO-ONCOLOGY
'The Why' | Imugene, Developing Cancer Immunotherapies ASX: IMU
How Imugene (ASX: IMU) is changing the lives of cancer patients #shorts
Combination CAR T Oncolytic Virus Immunotherapy Kills Tumors
Imugene's HER-Vaxx Immunotherapy Treatment: Explained
Imugene: A worldwide license to attack blood cancer
ASX/ausbiz Biotech Unlocked with Imugene CEO Leslie Chong
Imugene's CEO interviewed on ausbiz detailing a clinical trial deal with Merck Germany and Pfizer.
Imugene (ASX:IMU) talks Phase 1 & 2 cancer trials
Imugene CEO Leslie Chong presents at Wholesale Investor's Virtual Showcase July 2020
